ArticleFolia microbiologica2025
Role of gene PA2798 on biofilm formation and virulence factors production of Pseudomonas aeruginosa.
Article in Folia microbiologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Bacterial biofilm formation plays a critical role in the pathogenicity and virulence of Pseudomonas aeruginosa posing a significant threat to human health. Previously, the uncharacterized P. aeruginosa gene PA2798, was identified as a contributor to its resistance to antibiofilm peptide. However, the functional role of PA2798 and the underlying mechanisms by which it regulates biofilm formation and virulence factor production remain largely unexplored. In this study, a PA2798-deficient mutant (PAO1∆PA2798) was constructed, and aminoglycosides minimum inhibitory concentrations (MICs) were measured to assess the effect of PA2798 on antibiotic susceptibility. In addition, both in vitro phenotypic assays and in vivo experiments in chronic and acute lung infection mice models were performed to evaluate the role of PA2798 in bacterial biofilm associated infection and its potential as an antimicrobial target. Results demonstrated that deletion of PA2798 led to fourfold decreases in MICs for gentamicin, amikacin, tobramycin and netilmicin, and was accompanied by reduced biofilm biomass and virulence factor production in PAO1∆PA2798. Moreover, compromised cellular integrity, reduced bacterial activity, and impaired bacterial motility were observed in PAO1∆PA2798. Simultaneously, mice infected with this mutant strain were observed with the reduction of bacterial colonization and improved survival in both chronic and acute in vivo models. Conclusively, our findings support a role for PA2798 in aminoglycoside resistance, biofilm formation and virulence factor production in P. aeruginosa, highlighting its potential as a target for therapeutic intervention in biofilm-associated infections.
Indexed as
Identifiers
41085950What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.